Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RSSS
RSSS logo

RSSS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Research Solutions Inc (RSSS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.550
1 Day change
-1.54%
52 Week Range
4.120
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Research Solutions Inc (RSSS) is not a strong buy at this moment for a beginner investor with a long-term strategy. The company's financial performance is weak, with declining revenue, net income, and EPS. Additionally, there are no significant positive catalysts or trading signals to suggest immediate upside potential. While the technical indicators are neutral, the lack of strong growth trends and the absence of recent positive news or trading activity make this stock a hold for now.

Technical Analysis

The MACD is above 0 and positively contracting, indicating a slight bullish sentiment. RSI is neutral at 55.05, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 2.42, with resistance at 2.541 and support at 2.298.

Positive Catalysts

  • Gross margin increased by 7.37% YoY, indicating some operational efficiency improvements.

Neutral/Negative Catalysts

  • Revenue dropped by 1.02% YoY, net income fell by 127.62% YoY, and EPS declined by 128.57% YoY. Analysts lowered the price target from $6 to $5 due to churn in B2C and declines in Transactions revenue. No recent news or significant trading activity from insiders, hedge funds, or Congress.

Financial Performance

In Q2 2026, revenue dropped to $11,792,651 (-1.02% YoY), net income dropped to $546,919 (-127.62% YoY), and EPS dropped to 0.02 (-128.57% YoY). Gross margin increased to 49.7%, up 7.37% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Maxim lowered the price target from $6 to $5 but maintained a Buy rating. The revenue miss was attributed to churn in B2C and declines in Transactions revenue, though adjusted EBITDA beat estimates due to cost controls and margin expansion.

Wall Street analysts forecast RSSS stock price to rise
3 Analyst Rating
Wall Street analysts forecast RSSS stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 2.550
sliders
Low
5
Averages
5.33
High
6
Current: 2.550
sliders
Low
5
Averages
5.33
High
6
Maxim
Maxim
Buy
downgrade
$6 -> $5
AI Analysis
2026-02-13
Reason
Maxim
Maxim
Price Target
$6 -> $5
AI Analysis
2026-02-13
downgrade
Buy
Reason
Maxim lowered the firm's price target on Research Solutions to $5 from $6 and keeps a Buy rating on the shares. The company's revenue was below estimates and consensus due to churn in B2C and declines in Transactions revenue, while adjusted EBITDA was in line with consensus and beat Maxim estimate due to cost controls and continued margin expansion, the analyst tells investors in a research note.
Roth Capital
Buy
maintain
$5
2025-09-19
Reason
Roth Capital
Price Target
$5
2025-09-19
maintain
Buy
Reason
Roth Capital raised the firm's price target on Research Solutions to $5 from $4.35 and keeps a Buy rating on the shares. The company pre-announced good Q4 results in mid-August, with core recurring platform revenues above the firm's forecast to largely offset soft transactions revenues, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for RSSS
Unlock Now

People Also Watch